Sign In | 0 items - USD $0.00 | Search | Compare 简体中文

Products Content

Blog

Tau Oligomers

Tau Oligomers in Alzheimer’s Disease

Brenda Knox | April 29th, 2022 | Scientific Review

Webinar: Labroots Neuroscience, Dr. Jacob McPhail

Webinar: Tools for Alzheimer’s & Parkinson’s Research

Brenda Knox | March 18th, 2022 | Webinar

Amyloid Hypothesis vs Tau Hypothesis: Plaques, Tangles, and the Pathology of Alzheimer's Disease

Amyloid Hypothesis vs Tau Hypothesis

Brenda Knox | March 10th, 2022 | Scientific Review

Holiday Office Hours 2021

Val Koutougos | December 6th, 2021 | Announcements

Wild-Type Tau in Alzheimer’s Disease

Brenda Knox | November 25th, 2021 | Scientific Review

Akt Signaling

Akt Signaling, Cell Growth and Survival

Brenda Knox | October 19th, 2021 | Scientific Review

IHC analysis using DNA Damage Antibody, (SMC-155)

Oxidative DNA Damage and its Role in Disease

Brenda Knox | September 17th, 2021 | Scientific Review

Characterizing Pathogenic Protein Aggregates for Utilization as Molecular Tools to Accelerate Neurodegenerative Disease Research

Webinar: Accelerating Neurodegenerative Disease Research with Pathogenic Protein Aggregates

Brenda Knox | September 14th, 2021 | Webinar

Wild Type SOD1 in ALS

The Role of Wild Type SOD1 in ALS

Brenda Knox | September 1st, 2021 | Scientific Review

Targeting Alpha Synuclein Aggregation with CBP/p300 Inhibitors: A Novel Approach in Parkinson’s Disease Therapeutics

Christina Korgiopoulou | August 13th, 2021 | Product Citation Reviews